•
Mar 31, 2023

Stoke Therapeutics Q1 2023 Earnings Report

Total Revenue
$5.51M
Previous year: $3M
+83.7%
EPS
-$0.53
Previous year: -$0.66
-19.7%
Gross Profit
$4.01M
Previous year: $2.38M
+68.6%
Cash and Equivalents
$190M
Previous year: $84.1M
+126.3%
Free Cash Flow
-$21.5M
Previous year: $31.7M
-168.0%
Total Assets
$282M
Previous year: $316M
-10.8%

Stoke Therapeutics

Stoke Therapeutics